News All News

Connie Cepko reflects on four decades of advancing efforts to prevent or treat vision-threatening disease. The Cepko Lab is highly translational, advancing research with support from the Blavatnik Biomedical Accelerator and by collaborating with industry, resulting in over 40 inventions from the lab.

Axoft, a startup launched with technology developed in Harvard labs, is transforming care for traumatic brain injuries with its soft, biocompatible neural probe that can quickly measure recovery and consciousness within a few minutes.

Bioengineering researchers at the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have developed a soft, thin, stretchable bioelectronic device that can be implanted into a tadpole embryo’s brain and record electrical activity with no impact on normal tadpole embryo development or behavior. This novel device could help researchers better understand and treat diseases that manifest in early brain development.

Investigating the reasons behind the stall in the decline of cardiovascular disease deaths in the U.S. and the new scientific innovations emerging from Harvard labs that aim to improve treatment and drive death rates down.